ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 95

Hip Osteoarthritis and Risk Of All Cause and Disease-Specific Mortality Among Older Women: A Population-Based Cohort Study

Kamil E. Barbour1, Li-Yung Lui2, Charles G. Helmick3, Kristina A. Theis4, Michael C. Nevitt5, Nancy E. Lane6, Louise Murphy1, Jennifer M. Hootman7, Marc C. Hochberg8 and Jane A. Cauley9, 1Centers for Disease Control and Prevention, Atlanta, GA, 2California Pacific Medical Center, San Francisco, CA, San Francisco, CA, 3National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, 4Athritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 5Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 6Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA, 7Division of Population Health, Centers for Disease Control and Prevention, Kennesaw, GA, 8Medicine, University of Maryland School of Medicine, Baltimore, MD, 9Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Hip, morbidity and mortality and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services I

Session Type: Abstract Submissions (ACR)

Background/Purpose: The morbidity of osteoarthritis (OA) is well documented; however few comprehensive studies have examined the effect of OA on mortality.  

Methods: We used data from the Study of Osteoporotic Fractures, a US population-based cohort study of 9704 white women, ages 65 years or older. Hip radiographs were obtained at baseline (1986-1988) and visit 5 (1995-1996). A summary Croft grade of 0–4 for each hip was based on 5 individual radiographic features: joint space narrowing (JSN), osteophytes, subchondral sclerosis, cysts formation, and deformity of the femoral head.  Radiographic hip OA (RHOA) was defined as having Croft grade of ≥2 in at least one hip (definite JSN or osteophytes plus one other radiographic feature).  Clinical hip OA (CHOA) was defined as having both RHOA and self-report of hip pain “on most days for at least one month in the year” in the same hip. Mortality was confirmed through July, 2012 by death certificates and hospital discharge summaries, if available. All-cause mortality (cumulative incidence=64%) was analyzed along with three disease-specific causes of death (ICD-9-CM, cumulative incidence): cardiovascular disease (CVD) (390-459.9, 24.8%), total cancer (140-239.9, 11.5%), gastrointestinal disease (520-579.9, 1.8%), and all other causes (25.9%). Cox proportional hazards regression with time-dependent covariates (at baseline and visit 5) were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs). All disease-specific mortality models accounted for competing risks of mortality.

Results: Mean follow-up time was 16.0 ± 6.1 years.  The baseline prevalence of RHOA and CHOA was 7.4% and 3.2%, respectively, whereas the visit 5 prevalence was higher (9.7% and 3.9%, respectively). Having RHOA was associated with increased risk of all-cause [HR: 1.20; 95% CI: (1.10, 1.31)] and CVD [HR: 1.29; 95% CI: (1.13, 1.48)] mortality after adjusting for age, body mass index, health status, walking for exercise, diabetes, and stroke. Adjusting for potential mediating factors (i.e., physical function, falls, and disability) did not markedly attenuate these associations. CHOA was not associated with all-cause or any disease-specific mortality outcomes.

Conclusion: RHOA was associated with an increased risk of all-cause and CVD mortality in a cohort of older white women followed for a mean of 16 years.


Disclosure:

K. E. Barbour,
None;

L. Y. Lui,
None;

C. G. Helmick,
None;

K. A. Theis,
None;

M. C. Nevitt,
None;

N. E. Lane,
None;

L. Murphy,
None;

J. M. Hootman,
None;

M. C. Hochberg,
None;

J. A. Cauley,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hip-osteoarthritis-and-risk-of-all-cause-and-disease-specific-mortality-among-older-women-a-population-based-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology